An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis Bullosa	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, epidermolysis bullosa, hereditary disease, hereditary skin disorder, skin disorder, vesiculobullous skin disease	Not yet recruiting	Phase 3	2026-09-09		NCT07482813

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Paradigm Therapeutics	2

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials